Dermalex Eczema ‘Breakthrough’ Claim Breaks Down In UK Review
This article was originally published in The Rose Sheet
Executive Summary
Omega Pharma argues its product provides eczema treatment with multiple benefits commonly available only by using separate products – emollients to protect skin from moisture loss and reducing dryness and topical corticosteroids to reduce inflammation and redness.
You may also be interested in...
Omega Pharma's On-Screen Text Fails UK Ad Regulator's Reading Test
The UK Advertising Standards Authority orders Omega Pharma to discontinue an ad for Broncho Stop cough syrup as onscreen text intended to qualify claims was not legible. ASA notes the text met ad guidelines for size, but was compressed and difficult to read.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.